Should the 'echo guidelines' be followed in cancer patients?

Future Oncol. 2015;11(14):2021-5. doi: 10.2217/fon.15.109.

Authors

Joerg Herrmann¹, Eric H Yang²

Affiliations

¹ Division of Cardiovascular Disease, Mayo Clinic & College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
² Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

PMID: 26198830
DOI: 10.2217/fon.15.109

No abstract available

Keywords: cardiotoxicity; echocardiography; surveillance.

MeSH terms

Antineoplastic Agents / adverse effects
Cardiotoxicity / diagnosis
Cardiovascular Diseases / diagnosis*
Cardiovascular Diseases / etiology
Echocardiography*
Follow-Up Studies
Guidelines as Topic
Heart Failure / prevention & control
Humans
Neoplasms / complications*
Neoplasms / physiopathology
Survivors
Troponin C / blood
Ventricular Dysfunction, Left / diagnosis

Substances

Antineoplastic Agents
Troponin C